Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · IEX Real-Time Price · USD

5.05

+0.13 (2.54%)

At close: Jul 19, 2024, 4:30 PM

5.08

+0.04 (0.69%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Champions Oncology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Champions Oncology stock has a target of 7.50, which predicts an increase of 48.66% from the current stock price of 5.05.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.50	$7.50	$7.50	$7.50
Change	+48.66%	+48.66%	+48.66%	+48.66%

* Price targets were last updated on Sep 22, 2023.

Analyst Ratings

The average analyst rating for CSBR stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '24	Jun '24	Jul '24
Strong Buy	1	1	1
Buy	0	0	0
Hold	1	1	1
Sell	0	0	0
Strong Sell	0	0	0
Total	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 13, 2024
Scott Henry Roth MKM	Roth MKM	Strong Buy Maintains $9 → $7.5	Strong Buy	Maintains	$9 → $7.5	+48.66%	Sep 22, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

54.75M

from 50.16M

9.16%

from 50.16M

Revenue Next Year

70.99M

from 54.75M

29.66%

from 54.75M

EPS This Year

-0.35

from -0.54

EPS Next Year

n/a

from -0.35

Year	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029
Revenue	32.12M	41.04M	49.11M	53.87M	50.16M	54.75M	70.99M	81.64M	95.93M	113.19M
Revenue Growth	18.68%	27.76%	19.66%	9.69%	-6.90%	9.16%	29.66%	15.00%	17.50%	18.00%
EPS	-0.18	0.02	0.04	-0.39	-0.54	-0.35	-	-	-	-
EPS Growth	-	-	100.00%	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	56.4M	73.1M	84.0M	98.7M	116.5M
Avg	54.7M	71.0M	81.6M	95.9M	113.2M
Low	52.6M	68.2M	78.4M	92.2M	108.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.4%	33.5%	18.4%	21.0%	21.5%
Avg	9.2%	29.7%	15.0%	17.5%	18.0%
Low	4.9%	24.6%	10.5%	12.9%	13.4%

EPS Forecast

EPS	2025
High	-0.36
Avg	-0.35
Low	-0.33

EPS Growth

EPS Growth	2025
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.